Professional Documents
Culture Documents
Die (20 Versus 12 Percent) Experience An Embolic Event (60 Versus 31 Percent) Have A CNS Event (20 Versus 13 Percent) Not Undergo Surgery (26 Versus 39 Percent
Die (20 Versus 12 Percent) Experience An Embolic Event (60 Versus 31 Percent) Have A CNS Event (20 Versus 13 Percent) Not Undergo Surgery (26 Versus 39 Percent
Die (20 Versus 12 Percent) Experience An Embolic Event (60 Versus 31 Percent) Have A CNS Event (20 Versus 13 Percent) Not Undergo Surgery (26 Versus 39 Percent
endocarditis
The incidence of predisposing conditions (eg, rheumatic
heart disease and injection drug use) has varied over
time and among different areas.
EPIDEMIOLOGY — Sex and age have an impact on the
incidence of IE. Men predominate in most case
Endocarditis has increasingly become a disease of the
elderly.
Characteristics of patients with S. aureus IE vary by
region.
Compared with patients with IE due to other organisms,
patients with S. aureus IE were significantly more likely
to:
Pregnancy
Peritoneovenous shunts for the control of intractable
ascites
Ventriculoatrial shunts for the management of
hydrocephalus
In addition, patients with ulcerative lesions of the colon
due to carcinoma or inflammatory bowel disease have a
poorly understood predilection to develop endocarditis
secondary to Streptococcus bovis
Diagnostic approach to infective endocarditis
Usually based upon a constellation of clinical findings
rather than a single definitive test result.
The diagnosis is usually obvious when a patient has the
characteristic findings of IE:
Numerous positive blood cultures in the presence of a
well recognized predisposing cardiac lesion
Evidence of endocardial involvement
DIAGNOSTIC CRITERIA — The diagnosis of IE is based
upon a careful history and physical examination, blood
culture and laboratory results, an electrocardiogram
(ECG), a chest radiograph, and an echocardiogram.
Blood cultures
Electrocardiogram
Chest radiograph
Echocardiography
CULTURE-NEGATIVE ENDOCARDITIS — Culture-negative
endocarditis should be considered in patients with
negative blood cultures and persistent fever with one or
more clinical findings consistent with IE (eg, stroke or
other manifestations of emboli). Culture-negative IE
should also be considered in patients with a vegetation
on echocardiogram with no clear microbiologic diagnosis.
Persistent bacteremia
Evidence of active endocardial pathology (eg, the
presence of a new regurgitant murmur)
Predisposing valvular heart disease
The presence of vascular phenomena such as emboli or
splinter hemorrhages
DUKE CRITERIA —modified the von Reyn criteria to
include the role of echocardiography in diagnosis.
Rejected endocarditis —
A firm alternate diagnosis is made
Resolution of clinical manifestations occurs after four
days of antibiotic therapy or less
No pathological evidence of infective endocarditis is
found at surgery or autopsy after antibiotic therapy for
four days or less
Clinical criteria for possible or definite infective
endocarditis not met
Major clinical criteria:
Fever
The presence of a predisposing valvular
"Vascular phenomenon" such as emboli to organs or the
brain, hemorrhages in the mucous membranes around
the eyes.
"Immunologic phenomenon" such as glomerulonephritis,
or lesions such as Roth's spots (in the retina of the eyes)
or "Osler's nodes (nodules on the fingers or toes)
Positive blood cultures that do not meet the strict
definitions of a major criterion.
Cardiac
Septic
Embolic
Neurologic
Musculoskeletal
Renal
Associated with medical treatment
BUT,patients with neurologic involvement can
simultaneously have embolic and septic processes.
Stroke
Blindness
Painful ischemic or frankly gangrenous extremities
Unusual pain syndromes (eg, due to splenic or renal
infarction)
Hypoxia (due to pulmonary emboli in right-sided
endocarditis)
Paralysis (due to embolic infarction of either the brain or
spinal cord)
Acute myocardial infarction
Endocarditis should be considered as a possible etiology
in virtually all patients who present with signs or
symptoms of systemic arterial embolization.
Symptomatic embolization appears to be more common
with IE due to fungal pathogens.
Effect of antibiotic therapy on embolic risk — The risk of
embolization tends to decline after the institution of
effective antimicrobial therapy, and serious embolic
events rarely occur several weeks after such therapy is
instituted
Predictors of embolization —vegetation size is generally
a risk factor for embolization.
Embolic stroke
Acute encephalopathy
Meningoencephalitis
Purulent or aseptic meningitis
Cerebral hemorrhage (due to stroke or a ruptured
mycotic aneurysm)
Brain abscess or cerebritis
Seizures (secondary to abscess or embolic infarction)
Thus, the possibility of IE should be considered in all
patients who present with strokes, meningitis, or a brain
abscess. Unexplained fever accompanying a stroke in a
patient with valvular disease is an important clue in some
patients.
MYCOTIC ANEURYSMS — Mycotic aneurysms can occur
in the cerebral or systemic circulation of patients with IE,
usually at points of vessel bifurcation.
RENAL DISEASE — Renal infarction , drug-induced acute
interstitial nephritis, glomerulonephritis and, rarely,
renal abscess can occur in patients with IE.
Acute renal failure, defined as a serum creatinine of 2
mg/dL or greater, has been reported in up to one-third of
patients.
METASTATIC ABSCESSES — Rarely, metastatic abscesses
develop in the kidneys, spleen, brain or soft tissues.
Persistent fever during or after treatment for IE and
occasionally recurrent bacteremia after cure of the
valvular infection may be the only clues to the presence
of this complication.
Abscess formation occurs as a sequela of septic
embolization. Some patients with IE and brain abscesses
also have purulent meningitis.
MUSCULOSKELETAL COMPLICATIONS — Vertebral
osteomyelitis is a well known but relatively rare
complication of IE. severe back pain in any patient with IE
should alert the clinician to this possibility.
Acute septic arthritis, involving one or more joints, may
be the first clue to the presence of IE in a small
percentage of patients.
COMPLICATIONS OF MEDICAL OR SURGICAL THERAPY
—Aminoglycoside-induced ototoxicity or nephrotoxicity
Secondary bacteremia due to central vascular lines
Mediastinitis or early postoperative prosthetic valve
endocarditis
Intravenous catheter-associated phlebitis
Drug fever
Allergic or idiosyncratic reactions to various antimicrobial
agents
Bleeding due to disturbances in coagulation caused by
anticoagulants
Miesso(MD)